Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.

Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM

首页> 外文期刊>British Journal of Haematology >Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.

【24h】

Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.

机译：自体干细胞移植对于R-CHOP化疗后复发且对挽救性化疗有反应的患者仍然有益。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The initial results of the Collaborative Trial in Relapsed Aggressive Lymphoma (CORAL) study have recently been reported (Gisselbrecht et al, 2010). This study focused on the comparison of R-DHAP (dexamethasone, cytarabine, cisplatin, rituximab) versus R-ICE (ifosfamide, carboplatin, etoposide, rituximab) salvage chemotherapy in patients with diffuse large B cell lymphoma (DLBCL) in first relapse or refractory to first-line chemotherapy. Patients who achieved a complete (CR) or partial response (PR) went on to autologous stem cell transplantation (ASCT).

机译：最近已经报道了在复发性侵袭性淋巴瘤（CORAL）研究中进行的合作试验的初步结果（Gisselbrecht等，2010）。这项研究的重点是在初次复发或难治性弥漫性大B细胞淋巴瘤（DLBCL）患者中，R-DHAP（地塞米松，阿糖胞苷，顺铂，利妥昔单抗）与R-ICE（异环磷酰胺，卡铂，依托泊苷，利妥昔单抗）抢救化疗的比较进行一线化疗。达到完全缓解（CR）或部分缓解（PR）的患者继续进行自体干细胞移植（ASCT）。

著录项

来源
《British Journal of Haematology》 |2012年第1期|共2页
作者
Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy. [J] . Moore S, Peggs K, Thomson K, British Journal of Haematology . 2012,第1期

机译：自体干细胞移植对于R-CHOP化疗后复发且对挽救性化疗有反应的患者仍然有益。
2. Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant [J] . CzyzA., Romejko-JarosinskaJ., Knopinska-PoslusznyW., Leukemia and lymphoma . 2013,第5期

机译：基于含吉西他滨的挽救性化疗的治疗策略，旨在进行霍奇金淋巴瘤在先前自体移植后复发的患者中进行第二次干细胞移植
3. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): A randomised, open-label, phase 3 trial [J] . CookG., WilliamsC., BrownJ.M., The lancet oncology . 2014,第8期

机译：大剂量化疗加自体干细胞移植作为巩固疗法治疗先前自体干细胞移植后复发的多发性骨髓瘤患者（NCRI骨髓瘤X复发[强化试验]）：一项随机，开放标签的3期试验
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Posttraumatic stress disorder and sub-syndromal trauma symptoms in cancer patients treated with autologous hematopoietic stem cell transplant and standard dose chemotherapy. [D] . Gourvitz, Ross L. 2008

机译：自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
6. Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin’s lymphoma responding to prior salvage therapy [O] . Raynier Devillier, Diane Coso, Luca Castagna, 2012

机译：自体干细胞移植时的正电子发射断层扫描反应可预测复发和/或难治性霍奇金淋巴瘤患者对先前的挽救疗法有反应的结果
7. Second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma: Improved outcomes in patients with longer disease free interval after first autologous stem cell transplantation [O] . Mikhael J., Samiee S., Stewart A.K., 2006

机译：复发性多发性骨髓瘤患者的第二次自体干细胞移植作为挽救疗法：第一次自体干细胞移植后无疾病间隔时间更长的患者的预后得到改善

Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.

摘要

著录项

相似文献

相关主题

期刊订阅